Specgx LLC

Tsz Chung Lai

Kai Feng

Jonathan Gaik

Alex Micka

Jae Han Park

Rebecca Sue Walker

Clifford J Herman

Jaehan Park

Brad L Gower

Chirag Patel

Alexander Brian Lippold

The present disclosure provides pharmaceutical compositions that provide immediate release of active ingredients and have abuse deterrent properties. In particular, the pharmaceutical compositions comprise at least one pharmaceutically active ingredient, at least one non-cellulose polysaccharide, at least one hydrophilic gelling polymer, and an effervescent system.

Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides

Capsule dosage forms that provide immediate release of active ingredients and have abuse deterrent properties. In particular, the dosage forms comprise at least one pharmaceutically active ingredient, a combination of hydrophilic gelling polymers, at least one organic acid, and at least one disintegrant.

Abuse deterrent immediate release capsule dosage forms

A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition provides extended release of the API and has abuse deterrent features.

Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties

Delayed sustained release pharmaceutical compositions that provide therapeutic effects over extended periods of time (i.e., 14-16 hours).

Delayed sustained release pharmaceutical compositions

Growing community of inventors

Hazelwood, MO, United States of America

Tsz Chung Lai